M.R. Aberturas
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems 11
- Drug Solubulity and Delivery Systems 6
- Advancements in Transdermal Drug Delivery 3
- Biomaterials top 5%
- Molecular Medicine top 10%
- Pharmacology top 10%
- Cannabis and Cannabinoid Research 5
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments 3
-
- Pharmacological Effects and Toxicity Studies 5
-
- Drug Transport and Resistance Mechanisms 3
-
- RNA Interference and Gene Delivery 3
- Co-authors
- Jesús MolpeceresM. GuzmánMaría Esther Gil-AlegreAlessia LigrestiVincenzo Di MarzoAna Isabel Torres‐SuárezMar LorenteSofía Torres
In The Last Decade
M.R. Aberturas
25 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 111
- Pharmaceutical Science 477
- Biomaterials 329
- Molecular Medicine 52
- Pharmacology 170
- Transplantation 20
Countries citing papers authored by M.R. Aberturas
This map shows the geographic impact of M.R. Aberturas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.R. Aberturas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.R. Aberturas more than expected).
Fields of papers citing papers by M.R. Aberturas
This network shows the impact of papers produced by M.R. Aberturas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.R. Aberturas. The network helps show where M.R. Aberturas may publish in the future.
Co-authorship network
The 21 scholars most cited alongside M.R. Aberturas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 18 | |
| 2 | 2013 | 86 | |
| 3 | 2013 | 16 | |
| 4 | 2012 | 97 | |
| 5 | Estudio comparativo de disgregación de diferentes formulaciones de olanzapina | 2011 | 1 |
| 6 | 2011 | 11 | |
| 7 | 2010 | 32 | |
| 8 | 2002 | 44 | |
| 9 | 2001 | 39 | |
| 10 | 2000 | 168 | |
| 11 | 2000 | 19 | |
| 12 | 2000 | 19 | |
| 13 | 1999 | 148 | |
| 14 | 1998 | 10 | |
| 15 | 1997 | 20 | |
| 16 | 1996 | 24 | |
| 17 | 1996 | 120 | |
| 18 | 1993 | 35 | |
| 19 | 1992 | 52 | |
| 20 | 1989 | 3 |
About M.R. Aberturas
M.R. Aberturas is a scholar working on Pharmaceutical Science, Transplantation, Toxicology, Molecular Medicine and Pediatrics, Perinatology and Child Health, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (11 papers), Drug Solubulity and Delivery Systems (6 papers), Cannabis and Cannabinoid Research (5 papers), Pharmacological Effects and Toxicity Studies (5 papers), Advancements in Transdermal Drug Delivery (3 papers), Renal Transplantation Outcomes and Treatments (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Pharmaceutical Science (477 citations), Biomaterials (329 citations), Molecular Medicine (52 citations), Pharmacology (170 citations) and Transplantation (20 citations). M.R. Aberturas has collaborated with scholars based in Spain, Italy and Ukraine. Frequent co-authors include Jesús Molpeceres, M. Guzmán, María Esther Gil-Alegre, Alessia Ligresti, Vincenzo Di Marzo, Ana Isabel Torres‐Suárez, Mar Lorente, Sofía Torres, Elena García-Taboada and Guillermo Velasco. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Microencapsulation, Journal of Pharmaceutical Sciences, European Journal of Pharmaceutical Sciences and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.